Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $9.46 billion. The enterprise value is $11.46 billion.
Important Dates
The last earnings date was Tuesday, February 17, 2026, after market close.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HALO has 117.60 million shares outstanding. The number of shares has decreased by -4.27% in one year.
| Current Share Class | 117.60M |
| Shares Outstanding | 117.60M |
| Shares Change (YoY) | -4.27% |
| Shares Change (QoQ) | -3.81% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 106.75% |
| Float | 116.21M |
Valuation Ratios
The trailing PE ratio is 31.44 and the forward PE ratio is 9.84.
| PE Ratio | 31.44 |
| Forward PE | 9.84 |
| PS Ratio | 6.91 |
| Forward PS | 5.68 |
| PB Ratio | 194.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.68 |
| P/OCF Ratio | 14.53 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 20.58, with an EV/FCF ratio of 17.79.
| EV / Earnings | 36.18 |
| EV / Sales | 8.21 |
| EV / EBITDA | 20.58 |
| EV / EBIT | 24.44 |
| EV / FCF | 17.79 |
Financial Position
The company has a current ratio of 4.66, with a Debt / Equity ratio of 43.89.
| Current Ratio | 4.66 |
| Quick Ratio | 3.30 |
| Debt / Equity | 43.89 |
| Debt / EBITDA | 3.85 |
| Debt / FCF | 3.32 |
| Interest Coverage | 25.87 |
Financial Efficiency
Return on equity (ROE) is 153.59% and return on invested capital (ROIC) is 18.78%.
| Return on Equity (ROE) | 153.59% |
| Return on Assets (ROA) | 12.78% |
| Return on Invested Capital (ROIC) | 18.78% |
| Return on Capital Employed (ROCE) | 19.97% |
| Weighted Average Cost of Capital (WACC) | 7.96% |
| Revenue Per Employee | $3.99M |
| Profits Per Employee | $905,397 |
| Employee Count | 350 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.44 |
Taxes
In the past 12 months, HALO has paid $149.99 million in taxes.
| Income Tax | 149.99M |
| Effective Tax Rate | 32.13% |
Stock Price Statistics
The stock price has increased by +38.07% in the last 52 weeks. The beta is 0.98, so HALO's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +38.07% |
| 50-Day Moving Average | 70.85 |
| 200-Day Moving Average | 65.63 |
| Relative Strength Index (RSI) | 64.80 |
| Average Volume (20 Days) | 1,875,987 |
Short Selling Information
The latest short interest is 13.52 million, so 11.49% of the outstanding shares have been sold short.
| Short Interest | 13.52M |
| Short Previous Month | 13.59M |
| Short % of Shares Out | 11.49% |
| Short % of Float | 11.63% |
| Short Ratio (days to cover) | 7.55 |
Income Statement
In the last 12 months, HALO had revenue of $1.40 billion and earned $316.89 million in profits. Earnings per share was $2.56.
| Revenue | 1.40B |
| Gross Profit | 1.17B |
| Operating Income | 469.01M |
| Pretax Income | 466.88M |
| Net Income | 316.89M |
| EBITDA | 557.06M |
| EBIT | 469.01M |
| Earnings Per Share (EPS) | $2.56 |
Full Income Statement Balance Sheet
The company has $142.82 million in cash and $2.14 billion in debt, with a net cash position of -$2.00 billion or -$17.01 per share.
| Cash & Cash Equivalents | 142.82M |
| Total Debt | 2.14B |
| Net Cash | -2.00B |
| Net Cash Per Share | -$17.01 |
| Equity (Book Value) | 48.81M |
| Book Value Per Share | 0.41 |
| Working Capital | 648.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $651.56 million and capital expenditures -$6.97 million, giving a free cash flow of $644.59 million.
| Operating Cash Flow | 651.56M |
| Capital Expenditures | -6.97M |
| Free Cash Flow | 644.59M |
| FCF Per Share | $5.48 |
Full Cash Flow Statement Margins
Gross margin is 83.62%, with operating and profit margins of 33.58% and 22.69%.
| Gross Margin | 83.62% |
| Operating Margin | 33.58% |
| Pretax Margin | 33.43% |
| Profit Margin | 22.69% |
| EBITDA Margin | 39.89% |
| EBIT Margin | 33.58% |
| FCF Margin | 46.15% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.27% |
| Shareholder Yield | 4.27% |
| Earnings Yield | 3.35% |
| FCF Yield | 6.81% |
Analyst Forecast
The average price target for HALO is $77.27, which is -3.99% lower than the current price. The consensus rating is "Buy".
| Price Target | $77.27 |
| Price Target Difference | -3.99% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.92% |
| EPS Growth Forecast (5Y) | 29.06% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
| Last Split Date | Dec 10, 2003 |
| Split Type | Forward |
| Split Ratio | 4.275:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |